SIBP-A17 / Sinopharm - LARVOL DELTA

A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients. (clinicaltrials.gov) - P1 | N=196 | Recruiting | Sponsor: Shanghai Institute Of Biological Products | Trial completion date: Dec 2025 ➔ Dec 2026 | Trial primary completion date: Jul 2025 ➔ Jul 2026

Trial completion date • Trial primary completion date • Biliary Tract Cancer • Breast Cancer • Colorectal Cancer • Endometrial Cancer • Gastric Cancer • Gastrointestinal Cancer • HER2 Breast Cancer • Lung Cancer • Non Small Cell Lung Cancer • Ovarian Cancer • Solid Tumor • HER-2

A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients. (clinicaltrials.gov) - P1 | N=196 | Recruiting | Sponsor: Shanghai Institute Of Biological Products | Not yet recruiting ➔ Recruiting

Enrollment open • Metastases • Oncology • Solid Tumor

A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients. (clinicaltrials.gov) - P1 | N=196 | Not yet recruiting | Sponsor: Shanghai Institute Of Biological Products

Metastases • New P1 trial • Oncology • Solid Tumor